Initial Assessment of a Comprehensive Digital Smoking Cessation Program That Incorporates a Mobile App, Breath Sensor, and Coaching: Cohort Study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cigarette smoking is the leading cause of preventable morbidity and mortality, excess health care expenditure, and lost work productivity. Otherwise effective evidence-based treatments have had limited success owing to challenges with access, engagement, and scale. Pivot is a comprehensive digital smoking cessation program that incorporates a Food and Drug Administration-cleared carbon monoxide breath sensor, smartphone app, and text-based human coaching. OBJECTIVE: This initial evaluation of Pivot aimed to assess participant engagement, changes in attitudes toward quitting, and changes in smoking behavior. METHODS: US cigarette smokers aged 18 to 65 years who smoked ≥5 cigarettes per day (CPD) were recruited online. Participants completed a screening call, electronic informed consent, registration, and onboarding before beginning Pivot. Pivot includes 5 sequential stages (Explore, Build, Mobilize, Quit, and Secure), taking 14.5 to 18.5 weeks to complete. Data were collected via app and online questionnaires. Outcomes included engagement and retention (ie, weeks of active engagement and Pivot stage progression); attitudes toward quitting (ie, quit readiness, quit confidence, and expected difficulty maintaining quit); and smoking behavior (ie, quit attempts, cigarette reduction, and abstinence (7- and 30-day point prevalence abstinence [PPA]). RESULTS: A total of 319 participants completed onboarding (intention-to-treat [ITT] sample); 272/319 participants (85.3%) completed the end-of-Pivot questionnaire (study completer sample). Most (212/319, 66.5%) were not ready to quit in the next 30 days at baseline. On average, participants actively engaged in the program for a mean 12.4 (SD 7.1) weeks. Pivot stage completion rates were Explore: 88.7% (283/319), Build: 57.4% (183/319), Mobilize: 43.6% (139/319), Quit: 41.1% (131/319), and Secure: 39.5% (126/319). Repeated measures linear mixed model analyses demonstrated positive changes in attitudes from baseline to Mobilize (pre-Quit): increased confidence to quit (4.2 to 7.4, P<.001) and decreased expected difficulty maintaining quit (3.1 to 6.8, P<.001). The quit attempt rate (ie, those making ≥1 quit attempt lasting ≥1 day) was 79.4% (216/272, completer). At the end of Pivot, 7-day PPA rates were 32.0% (102/319, ITT) and 37.5% (102/272, completer); 30-day PPA rates were 27.6% (88/319, ITT) and 32.4% (88/272, completer). Moreover, 30-day PPA rates were comparable among those ready and not ready to quit in the next 30 days at baseline. Of those not achieving abstinence, 25.9% (44/170, completer) achieved ≥50% reduction in CPD by study end. CONCLUSIONS: This study evaluated Pivot's initial performance with comparable quit rates among those ready and not ready to quit in the next 30 days at entry. The present data, considered with the program's accessibility, innovation, evidence-based foundation, and design for all smokers, suggest Pivot has the potential to address limitations of reach and scale and thereby advance smoking cessation efforts. TRIAL REGISTRATION: ClinicalTrials.gov NCT03295643; https://clinicaltrials.gov/ct2/show/NCT03295643 (Archived by WebCite at http://www.webcitation.org/75TiNe6BE).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Quitting smoking among adults—United States, 2000-2015.
Babb, S., Malarcher, A., Schauer, G., Asman, K., & Jamal, A. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6552a1 · Cited by 1,147
Individual behavioural counselling for smoking cessation
Lancaster, T., & Stead, L. F. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001292.pub2 · Cited by 1,015
Vangeli, E., Stapleton, J., Smit, E. S., Borland, R., & West, R. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03565.x · Cited by 607 · cited 1×
“Previous evaluation has shown that changes in attitudes toward quitting are meaningful predictors of quit attempts [39].”
BackgroundSiu, A. L., & for the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-2023 · Cited by 515
Individual behavioural counselling for smoking cessation
Lancaster, T., & Stead, L. F. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001292.pub3 · Cited by 436 · cited 1×
“Specifically, Pivot uses the USCPG-recommended 5 As (Ask, Advise, Assess, Assist, and Arrange), tailors on readiness to quit [4], encourages the use of FDA-approved pharmacotherapy [4,26-28], capitalizes on effective methods for smoking cessation (eg, motivational interviewing, cognitive behavioral therapy, and self-d…”
Patnode, C. D., Henderson, J. T., Thompson, J. H., Senger, C. A., Fortmann, S. P., & Whitlock, E. P. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0171 · Cited by 238
Williams, G. C., Niemiec, C. P., Patrick, H., Ryan, R. M., & Deci, E. L. (2009) · Annals of Behavioral Medicine · doi:10.1007/s12160-009-9090-y · Cited by 201 · cited 1×
“Specifically, Pivot uses the USCPG-recommended 5 As (Ask, Advise, Assess, Assist, and Arrange), tailors on readiness to quit [4], encourages the use of FDA-approved pharmacotherapy [4,26-28], capitalizes on effective methods for smoking cessation (eg, motivational interviewing, cognitive behavioral therapy, and self-d…”
MethodSelf-citationMissing Data in Alcohol Clinical Trials: A Comparison of Methods
Hallgren, K. A., & Witkiewitz, K. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12205 · Cited by 176 · cited 1×
“However, this method is subject to biases in effect size estimates and may lead to errors [42,43].”
MethodProchaska, J. O., Norcross, J. C., & DiClemente, C. C. (2013) · Psychologists' Desk Reference · doi:10.1093/med:psych/9780199845491.003.0034 · Cited by 165
A comparison of the characteristics of iOS and Android users of a smoking cessation app
Ubhi, H. K., Kotz, D., Michie, S., van Schayck, O. C. P., & West, R. (2017) · Translational Behavioral Medicine · doi:10.1007/s13142-016-0455-z · Cited by 49
Krishnan, N., Elf, J. L., Chon, S., & Golub, J. E. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty182 · Cited by 34
Cited by
Challenges in Participant Engagement and Retention Using Mobile Health Apps: Literature Review
Amagai, S., Pila, S., Kaat, A. J., Nowinski, C. J., & Gershon, R. C. (2022) · Journal of Medical Internet Research · doi:10.2196/35120 · Cited by 343
“For example, mHealth apps created to support smoking cessation for adult smokers were more likely to be successful when participants were already highly motivated to stop smoking (eg, [18,40,72]).”
BackgroundWhat Works Best to Engage Participants in Mobile App Interventions and e-Health: A Scoping Review
Oakley-Girvan, I., Yunis, R., Longmire, M., & Ouillon, J. S. (2022) · Telemedicine and e-Health · doi:10.1089/tmj.2021.0176 · Cited by 92
Smoking cessation apps: a systematic review of format, outcomes, and features
Barroso-Hurtado, M., Suárez-Castro, D., Martínez-Vispo, C., Becoña, E., & López-Durán, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111664 · Cited by 58
Smartphone health apps for tobacco cessation: a systematic review
Chu, K.-H., Matheny, S. J., Escobar-Viera, C. G., Wessel, C., Notier, A. E., & Davis, E. M. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106616 · Cited by 43
Metadata
- Authors
- Marler, J. D., Fujii, C. A., Utley, D. S., Tesfamariam, L. J., Galanko, J. A., & Patrick, H.
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2019-02-04
- Volume
- 7
- Issue
- 2
- Pages
- e12609
- ISSN
- 2291-5222 (ISSN-L)
- OpenAlex
- W2909558125
- Cited by
- 42
- References
- 12
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.